NCT05427851

Diode Laser Pulpotomy of Mature Permanent Molars With Irreversible Pulpitis

Effect Of Diode Laser And Platelet Rich Fibrin In Regenerative Pulpotomy Of Mature Permanent Molars With Irreversible Pulpitis (A Randomized Controlled Clinical Trial)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Alexandria University · Academic / Other
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

Thirty six patients are included in this study. For each patient, a pulpotomy procedure is performed.

Detailed description

For each patient, a pulpotomy procedure is done. Group I (n=12) pulpotomy is performed and hemostasis is achieved by applying NaOCl, then the radicular pulp is covered with Platelet Rich Fibrin (PRF) and capped with Biodentine, Group II (n=12) pulpotomy is done as in group I and hemostasis is achieved using diode laser and remaining pulp is capped with Biodentine, Group III (n=12) pulpotomy is performed and hemostasis is achieved as in group II then radicular pulp is covered with PRF then capped with Biodentine, The teeth are then restored with Glass ionomer cement followed by composite restoration. Pain is recorded every 24 hours for 7 days after intervention. Clinical and radiographic follow-up are done at 1,3,6,9 and 12 months. Cone beam computed tomography (CBCT) is done immediate postoperative and will be used for the assessment of the outcome of the pulpotomy procedure at the end of the study period.

Conditions

• Irreversible Pulpitis

Interventions

Type	Name	Description
PROCEDURE	pulpotomy	coronal pulp tissue removal followed by radicular pulp hemostasis them applying a pulp capping material
DEVICE	Diode laser - fonalaser	diode laser beam application

Timeline

• Start date: 2019-04-10
• Primary completion: 2021-05-01
• Completion: 2022-09-01
• First posted: 2022-06-22
• Last updated: 2022-06-22

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated device study